Get in touch
Website Logo

Real World Evidence

Our solutions are designed with current and future patients in mind.

Insights across the product lifecycle

Real World Data (RWD) routinely collected on patient health and/or the delivery of care from sources other than clinical trials continues to play an increasing role in healthcare decision-making. The analysis of RWD provides an opportunity to generate Real World Evidence (RWE) capable of supplementary insights on the usage, potential benefits/risks and value proposition of medicinal products and medical devices.

‘The analysis of Real World Data provides an opportunity to generate Real World Evidence.’

Case studies

Global Oncology Phase 3 Rescue Study

Appointed to rescue a full-service, global, randomized Phase 3 oncology trial from a CRO failing to meet a biotechnology client’s expectations regarding enrollment and cost.

Case Studies

Global EAP for a specialized biotech company

Requirement for a global EAP of a rare disease on behalf of a US biotech partner.

Case Studies

European EAP with tailored RWD strategy

Rapid set-up of EAP for a rare oncology product.

Case Studies